Reed Sheppard
Story Poster
5 Thoughts: Ags extend stay in Nashville for Friday clash with Kentucky
8 mo ago by Tom Schuberth
Texas A&M earned another night's stay in Music City after an 80-71 victory over Ole Miss in the second round of the SEC Tournament. The Aggies hope to prolong their stay in Nashville, facing 2-seeded Kentucky in Friday night's quarterfinals.
Story Poster
18:20
French: Aggies need to create 'organized chaos' to upset Kentucky
8 mo ago by Ryan Brauninger
Texas A&M took care of business in the second round of the SEC Tournament against Ole Miss to inch their way into the NCAA Tournament, for now, per Joe Lundari's Bracketology. Former Aggie guard Mark French joined TexAgs Radio to preview the quarterfinal vs. Kentucky.
Story Poster
31:27
Resilient Ags offer dramatic reminder in OT victory over No. 6 Kentucky
10 mo ago by Olin Buchanan
Not too long ago, Texas A&M was ranked as high as No. 12 in the AP poll, but after losses to LSU and Auburn, the Aggies were in danger of falling out of the SEC race. However, on Saturday, A&M pulled off the upset of No. 6 Kentucky in overtime, 97-92.
Get access to all Premium content today
Start your subscription for just $1
Try Premium Now
Story Poster
Scouting Report: Texas A&M vs. No. 6 Kentucky
10 mo ago by Tom Schuberth
John Calipari's youthful and fast No. 6 Kentucky Wildcats are riding a six-game win streak into Saturday's contest against Texas A&M at Reed Arena. With two SEC losses behind them, the Aggies seek their first conference victory and Buzz Williams' first against the Wildcats.
Story Poster
29:01
Reed Report: Stumbling to start SEC play, facing No. 6 Kentucky & more
10 mo ago by David Sandhop
Texas A&M basketball has slumped to a 0-2 start in conference play as the sixth-ranked Kentucky Wildcats come to Aggieland on Saturday. Ahead of this weekend's contest with Cal & Co., David Sandhop and Luke Evangelist sat down for another edition of the Reed Report.
 
×
subscribe Verify your student status
See Subscription Benefits
Trial only available to users who have never subscribed or participated in a previous trial.